Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity

被引:130
|
作者
Kok, SW
Overeem, S
Visscher, TLS
Lammers, GJ
Seidell, JC
Pijl, H
Meinders, AE
机构
[1] Leiden Univ, Med Ctr, Dept Gen Internal Med, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Neurol & Clin Neurophysiol, NL-2300 RC Leiden, Netherlands
[3] Natl Inst Publ Hlth & Environm, Dept Chron Dis Epidemiol & Environm Epidemiol, NL-3720 BA Bilthoven, Netherlands
来源
OBESITY RESEARCH | 2003年 / 11卷 / 09期
关键词
orexin; waist circumference; body fat; narcolepsy; body weight;
D O I
10.1038/oby.2003.156
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the prevalence of obesity among patients with narcolepsy, to estimate associated long-term health risks on the basis of waist circumference, and to distinguish the impact of hypocretin deficiency from that of increased daytime sleepiness (i.e., reduced physical activity) on these anthropometric measures. Research Methods and Procedures: A cross-sectional, case-control study was conducted. Patients with narcolepsy (n = 138) or idiopathic hypersomnia (IH) (n = 33) were included. Age-matched, healthy members of the Dutch population (Monitoring Project on Risk Factors for Chronic Diseases and Doetinchem Project; n = 10,526) were used as controls. BMI and waist circumference were determined. Results: Obesity (BMI 30 kg/m(2)) and overweight (BMI 25 to 30 kg/m(2)) occurred more often among narcolepsy patients [prevalence: 33% (narcoleptics) vs. 12.5% (controls) and 43% (narcoleptics) vs. 36% (controls), respectively; both p < 0.05]. Narcoleptics had a larger waist circumference (mean difference 5 +/- 1.4 cm, p < 0.001). The BMI of patients with IH was significantly lower than that of narcolepsy patients (25.6 +/- 3.6 vs. 28.5 +/- 5.4 kg/m(2); p = 0.004). Discussion: Overweight and obesity occur frequently in patients with narcolepsy. Moreover, these patients have an
引用
收藏
页码:1147 / 1154
页数:8
相关论文
共 50 条
  • [1] Attention impairments and ADHD symptoms in adult narcoleptic patients with and without hypocretin deficiency
    Filardi, Marco
    Pizza, Fabio
    Tonetti, Lorenzo
    Antelmi, Elena
    Natale, Vincenzo
    Plazzi, Giuseppe
    PLOS ONE, 2017, 12 (08):
  • [2] Narcolepsy: the impact of aging, hypocretin deficiency, and years of formal education in olfactory function and abdominal obesity
    Truzzi, Giselle de Martin
    Naufel, Maria Fernanda
    Tufik, Sergio
    Coelho, Fernando Morgadinho
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2021, 79 (09) : 808 - 815
  • [3] CSF hypocretin levels in Korean narcoleptic patients
    Lee, SP
    Hong, SC
    Han, JH
    Park, SA
    Jeong, JH
    Kim, HJ
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S383 - S383
  • [4] CSF hypocretin levels in Korean narcoleptic patients
    Hong, S
    Jeong, JH
    Han, JH
    Lee, SP
    Mignot, E
    SLEEP, 2003, 26 : A284 - A284
  • [5] Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans
    Kok, SW
    Meinders, AE
    Overeem, S
    Lammers, GJ
    Roelfsema, F
    Frölich, M
    Pijl, H
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (02): : 805 - 809
  • [6] Deficits of attention and cognition in narcoleptic patients - is it hypocretin dependent?
    Iatallese, Gislene Serafim
    Cremaschi, Renata Carvalho
    Coin de Carvalho, Luciane Bizari
    Tufik, Sergio
    Coelho, Fernando Morgadinho
    SLEEP MEDICINE, 2015, 16 (08) : 1024 - 1024
  • [7] Familial narcolepsy, obesity and type 2 diabetes with hypocretin deficiency
    Hor, H.
    Vicario, J.
    Pfister, C.
    Lammers, G.
    Tafti, M.
    Peraita-Adrados, R.
    SLEEP, 2008, 31 : A213 - A213
  • [8] Somatotropic axis in hypocretin-deficient narcoleptic humans:: altered circadian distribution of GH-secretory events
    Overeem, S
    Kok, SW
    Lammers, GJ
    Vein, AA
    Frölich, M
    Meinders, AE
    Roelfsema, F
    Pijl, H
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (03): : E641 - E647
  • [9] Effects of IV and ICV hypocretin-1 (Orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog
    Fujiki, N
    Yoshida, Y
    Ripley, B
    Mignot, E
    Nishino, S
    SLEEP, 2003, 26 (08) : 953 - 959
  • [10] Hypocretin immunoreactivity in the blood of genetically engineered narcoleptic mice models
    Yoshida, Y
    Mishima, K
    Taheri, S
    Sakurai, T
    Yanagisawa, M
    Mignot, E
    Nishino, S
    SLEEP, 2004, 27 : 249 - 249